Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone [Phase 3]
Phase 3 randomized trial evaluating adoptive family-matched cytotoxic T lymphocytes plus standard of care versus standard of care alone for …
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients [NA]
Clinical trial investigating using cytomegalovirus cell-mediated immunity to optimize the duration of letermovir prophylaxis in hematopoieti…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating cytomegalovirus immune globulin (CMVIG) prophylaxis in belatacept-converted kidney transplant recip…
-
EMA approval · 2025-10-22EMA Authorised: Livtencity (Maribavir) — Takeda Pharmaceuticals International AG Ireland Branch
EU authorised Livtencity (maribavir) for cytomegalovirus infections, with orphan medicine designation.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Study Evaluating the Efficacy and Safety of Artesunate [Phase 2]
This clinical trial update reports a Phase 2 study evaluating the efficacy and safety of artesunate for cytomegalovirus infection, currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients [Phase 3]
Phase 3 clinical trial of letermovir (Prevymis) for prevention of cytomegalovirus infection in kidney and pancreas transplant recipients is …
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients [Phase 4]
Phase 4 trial comparing maribavir vs valganciclovir for CMV prophylaxis in high-risk kidney transplant recipients has completed.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection
This update describes a study evaluating maribavir tablets for cytomegalovirus infection, which is currently recruiting participants.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR
A clinical trial update describing a study on monitoring HCMV using PSTM-qPCR after allogeneic hematopoietic stem cell transplantation; the …
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating a multi-antigen CMV-modified vaccinia Ankara vaccine in pediatric patients undergoing donor stem cell…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation. [Phase 2]
Phase 2 study evaluating Cytotect CP, a hyperimmune anti-CMV IVIg, as prophylaxis against cytomegalovirus infection in patients with acute g…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant [Phase 2, Phase 3]
A Phase 2/3 clinical trial compares valganciclovir with letermovir for CMV prophylaxis in heart transplant recipients and is currently recru…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants [Phase 1]
A Phase 1 clinical trial update evaluating the SPYVLP01 human cytomegalovirus vaccine, with and without adjuvants, has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia [Phase 2, Phase 3]
A clinical trial update reports a Phase 2/Phase 3 study evaluating empirical treatment for cytomegalovirus and tuberculosis in HIV-infected …
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation
The trial evaluated the clinical performance of SE-SPTM-PCR for detecting HCMV-miR-UL22A-5p after hematopoietic stem cell transplantation; t…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Evaluation of Software for Interpreting Virological Results Indicated for the Diagnosis of Cytomegalovirus (CMV) Infection During Pregnancy and Intended for Health Professionals
A clinical trial is evaluating software designed to help health professionals interpret virological test results for diagnosing cytomegalovi…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium
Takeda is recruiting adults in Belgium for a study of maribavir to treat post-transplant cytomegalovirus infection.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus [Phase 1, Phase 2]
This clinical trial update reports the completion of Phase 1/2 trials evaluating injections of CD4+ and CD8+ T cells targeting cytomegalovir…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: A Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus Infection
A prospective, single-arm observational study evaluating maribavir for cytomegalovirus infection after hematopoietic stem cell transplantati…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating virus-specific T-lymphocytes to treat infections with adenovirus, cytomegalovirus, and Epstein-Barr…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. [Phase 1]
Phase 1 clinical trial evaluating TETRAVI Multivirus CTLs to treat EBV, CMV, adenovirus, and BK virus infections in patients after allogenei…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection
A completed clinical trial evaluating maribavir for post-transplant Cytomegalovirus infection in adults.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) [Phase 2]
Phase 2 clinical trial evaluating Virus Specific Cytotoxic T-Lymphocytes to treat refractory cytomegalovirus infections in individuals with …
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.
This clinical trial update notes that the study assessing CMV infection risk in renal transplant recipients using the QuantiFERON-CMV test h…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: R-MVST Cells for Treatment of Viral Infections in Children and Young Adults [Phase 1]
Phase 1 trial evaluating R-MVST Cells for treatment of viral infections in children and young adults is currently recruiting, assessing safe…